Transfection reagents empowering discovery
Fugent LLC was founded in 1996 to inspire and enable healing discoveries. One of their first innovation FuGENE®6 was one of the first commercially available transfection reagents and is still an industry leader for transfecting DNA into eukaryotic cells. Fugent LLC later discovered the first non-liposomal 100% synthetic DNA transfection reagent, FuGENE®HD. This product is being used today in various biotechnology applications, from the gentle interrogation of cellular action to the production of vaccines and medicines.
FuGENE® has continued to innovate and now offers a full portfolio of best-in-class transfection reagents that span applications across DNA, RNA and CRISPR/Cas9 delivery, into a wide range of biologically relevant cell lines. The company seeks to meet the needs of researchers, scientists, and clinicians in delivering nucleic acids and proteins to cells at market-leading efficiencies while remaining gentle on cells.
* For Australian pricing, please call our office, contact us at email@example.com, or leave us a message for a quote here.
No products were found matching your selection.